FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leonard Saltz

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
K S Lee; Garrett M Nash; Philip B Paty; Diane Lauren Reidy; Leonard B Saltz; Jinru Shia; Laura H Tang; Larissa K Temple; Martin R Weiser; Jose G Guillem; Marc J Gollub
Goblet cell carcinoid neoplasm of the appendix: clinical and CT features.
James D Smith; Larissa K Temple; Martin R Weiser; Jeannine A Ruby; Leonard B Saltz; Karyn A Goodman; José G Guillem; Garrett M Nash; Philip B Paty
Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy.
Jeffrey A Meyerhardt; Rex B Mowat; Donna Niedzwiecki; Leonard B Saltz; Kaori Sato; Alan P Venook; Renaud Whittom; Devin S Wigler; Cynthia Ye; Al Benson; Alexander Hantel; Robert J Mayer; Charles S Fuchs
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leonard Saltz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: K S Lee; Garrett M Nash; Philip B Paty; Diane Lauren Reidy; Leonard B Saltz; Jinru Shia; Laura H Tang; Larissa K Temple; Martin R Weiser; Jose G Guillem; Marc J Gollub
Goblet cell carcinoid neoplasm of the appendix: clinical and CT features.
European journal of radiology 2013;82(1):85-9.
2012: James D Smith; Larissa K Temple; Martin R Weiser; Jeannine A Ruby; Leonard B Saltz; Karyn A Goodman; José G Guillem; Garrett M Nash; Philip B Paty
Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy.
Annals of surgery 2012;256(6):965-72.
2012: Jeffrey A Meyerhardt; Rex B Mowat; Donna Niedzwiecki; Leonard B Saltz; Kaori Sato; Alan P Venook; Renaud Whittom; Devin S Wigler; Cynthia Ye; Al Benson; Alexander Hantel; Robert J Mayer; Charles S Fuchs
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of the National Cancer Institute 2012;104(22):1702-11.
2012: Jean M Butte; Peter J Allen; Ronald P DeMatteo; Peirong Ding; Yuman Fong; Mithat Gonen; Karyn A Goodman; Jose Guillem; William R Jarnagin; Nancy E Kemeny; Garrett M Nash; Philip B Paty; Leonard B Saltz; Martin R Weiser; Michael I D'Angelica
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer.
Cancer 2012;118(21):5414-23.
2012: Yevgeniy Karamurzin; Hikmat Al-Ahmadie; Daniel G Coit; Eileen M O'Reilly; Ihsane Ouansafi; Philip B Paty; Leonard B Saltz; Christine Sempoux; Jinru Shia; Robert A Soslow; Zsofia Kinga Stadler; Zhaoshi Zeng; Liying Zhang; David S Klimstra
Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature.
Human pathology 2012;43(10):1677-87.
2012: Diane L Reidy-Lagunes; Marinela Capanu; Ellen M Hollywood; M Catherine Pietanza; Michal F Segal; David B Solit; Laura H Tang; Efsevia Vakiani; Leonard B Saltz
A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors.
Cancer 2012;118(19):4795-800.
2012: George A. Poultsides; Leonard B Saltz; Elliot L Servais; Jinru Shia; Ronald P DeMatteo; Yuman Fong; Tina Hernandez-Boussard; William R Jarnagin; Nancy E Kemeny; David S Klimstra; Peter J Allen; Fei Bao; Michael I D'Angelica
Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
Annals of surgical oncology 2012;19(9):2797-804.
2012: Efsevia Vakiani; Agnes Viale; Martin Weiser; Zhaoshi Zeng; Andrea Cercek Hanjis; Timothy Chan; Michael D'Angelica; Adriana Heguy; Manickam Janakiraman; Nancy Kemeny; Philip Paty; Leonard B Saltz; Ronglai Shen; Jinru Shia; Rileen Sinha; David B Solit
Comparative genomic analysis of primary versus metastatic colorectal carcinomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(24):2956-62.
2012: Neil H Segal; Leonard B Saltz
Antitumor activity in metastatic disease does not predict efficacy in the adjuvant setting.
JAMA : the journal of the American Medical Association 2012;307(13):1431-2.
2012: Jeannine A Ruby; Leonard B Saltz; Jinru Shia; Timothy J Akhurst; Steven M Larson; Tobias Leibold; Madhu Mazumdar; Elyn R Riedel; José G Guillem
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.
Diseases of the colon and rectum 2012;55(4):378-86.
2012: Shuji Ogino; Leonard B Saltz; Paul Schaefer; Kaori Shima; Donna Spiegelman; Renaud Whittom; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Nadine J McCleary; Jeffrey A Meyerhardt; Kimmie Ng; Al B Benson; Monica M Bertagnolli; Charles S Fuchs
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(3):890-900.
2012: Andrea Cercek Hanjis; Leonard B Saltz
Factors dictating outcomes in patients with colorectal cancer and peritoneal carcinomatosis: selection, resection, or convection?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(3):226-8.
2011: Anand Govindarajan; Jose G Guillem; Philip B Paty; Diane Reidy; Leonard B Saltz; Larissa K Temple; Martin R Weiser; Douglas Wong; Garrett M Nash
Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Annals of surgical oncology 2011;18(13):3666-72.
2011: J Cassidy; F Gilberg; P Hoff; Y Kang; J P Saini; Leonard B Saltz; Chris Twelves; Eric Van Cutsem; D Cunningham
Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(12):2604-9.
2011: Paul A Glare; Deborah Semple; Stacy M Stabler; Leonard B Saltz
Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria.
Journal of oncology practice / American Society of Clinical Oncology 2011;7(6):366-70.
2011: Kimmie Ng; Donna Niedzwiecki; Shuji Ogino; Leonard B Saltz; Paul L Schaefer; Alan P Venook; Renaud Whittom; Al B Benson; Monica M Bertagnolli; Andrew T Chan; Jennifer A Chan; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Jeffrey A Meyerhardt; Charles S Fuchs
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Journal of the National Cancer Institute 2011;103(20):1540-51.
2011: Tobias Leibold; Homer Macapinlac; Madhu Mazumdar; Bruce D Minsky; Philip B Paty; Elyn Riedel; Leonard B Saltz; Jinru Shia; Martin R Weiser; Douglas Wong; Henry W Yeung; Timothy J Akhurst; David B Chessin; Steven M Larson; José G Guillem
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
Annals of surgical oncology 2011;18(10):2783-9.
2011: Jean Wright; Marc J Gollub; José G Guillem; Bruce D Minsky; Philip B Paty; Leonard B Saltz; Larissa K Temple; Martin R Weiser; W Douglas Wong; Karyn A Goodman
Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal.
Diseases of the colon and rectum 2011;54(9):1090-7.
2011: Ghassan K Abou-Alfa; Leonard B Saltz
Doxorubicin and sorafenib for treatment of advanced hepatocellular cancer.
Gastroenterology 2011;141(3):e19-20; author reply e20-1.
2011: Monica M Bertagnolli; Thomas A Colacchio; Carolyn Corlies Compton; Richard M Goldberg; Robert J Mayer; Donna Niedzwiecki; Mark Redston; Leonard B Saltz; Robert S Warren
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3153-62.
2011: Herbert I Hurwitz; Leonard B Saltz; Eric Van Cutsem; James Cassidy; Jonas Wiedemann; Florin Sirzén; Gary H Lyman; Ulrich-Peter Rohr
Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(13):1757-64.
2011: Daniel Sargent; Q Shi; Greg Yothers; E Van Cutsem; J Cassidy; Leonard B Saltz; Norman Wolmark; B Bot; Axel Grothey; Marc Buyse; Aimery de Gramont
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803.
European journal of cancer (Oxford, England : 1990) 2011;47(7):990-6.
2010: Ghassan K Abou-Alfa; Philip Johnson; Jennifer J Knox; Marinela Capanu; Irina Davidenko; Juan Lacava; Thomas Leung; Bolorsukh Gansukh; Leonard B Saltz
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.
JAMA : the journal of the American Medical Association 2010;304(19):2154-60.
2010: Jean Wright; Sujata M Patil; Larissa K Temple; Bruce D Minsky; Leonard B Saltz; Karyn A Goodman
Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
International journal of radiation oncology, biology, physics 2010;78(4):1064-72.
2010: Wu Zhang; Mizutomo Azuma; Georg Lurje; Michael A Gordon; Dongyun Yang; Alexandra Pohl; Yan Ning; Pierre Bohanes; Armin Gerger; Thomas Winder; Ellen Hollywood; Kathleen D Danenberg; Leonard B Saltz; Heinz-Josef Lenz
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study).
Anticancer research 2010;30(10):4209-17.
2010: Leonard B Saltz
Adjuvant therapy for colon cancer.
Surgical oncology clinics of North America 2010;19(4):819-27.
2010: Kimmie Ng; Jeffrey A Meyerhardt; Jennifer A Chan; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Charlie S Fuchs
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4354-63.
2010: Diane Lauren Reidy; Efsevia Vakiani; Marwan G Fakih; Muhammad Wasif Saif; Joel Randolph Hecht; Noah Goodman-Davis; Ellen M Hollywood; Jinru Shia; Jonathan Schwartz; Kumari Chandrawansa; Aruna Dontabhaktuni; Hagop Youssoufian; David B Solit; Leonard B Saltz
Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4240-6.
2010: Ki Young Chung; Ira Gore; Lawrence Fong; Alan P Venook; Stephen B Beck; Prudence Dorazio; Peggy J Criscitiello; Diane I Healey; Bo Huang; Jesus Gomez-Navarro; Leonard B Saltz
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(21):3485-90.
2010: Manickam Janakiraman; Efsevia Vakiani; Zhaoshi Zeng; Christine A Pratilas; Barry S Taylor; Dhananjay Chitale; Ensar Halilovic; Manda Wilson; Kety Huberman; Julio Cezar Ricarte Filho; Yogindra Persaud; Douglas A Levine; James A Fagin; Suresh C Jhanwar; John M Mariadason; Alex E Lash; Marc Ladanyi; Leonard B Saltz; Adriana Heguy; Philip B Paty; David B Solit
Genomic and biological characterization of exon 4 KRAS mutations in human cancer.
Cancer research 2010;70(14):5901-11.
2010: Fidel-David Huitzil-Melendez; Marinela Capanu; Eileen O'Reilly; Austin Duffy; Bolorsukh Gansukh; Leonard B Saltz; Ghassan K Abou-Alfa
Advanced hepatocellular carcinoma: which staging systems best predict prognosis?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2889-95.
2010: JOSEPH HERMAN; Wells A Messersmith; W Warren Suh; William Blackstock; Bard C Cosman; Mohammed Mohiuddin; Matthew M Poggi; William F Regine; Leonard B Saltz; William Small; Jennifer Zook; Andre Konski
ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentation.
Current problems in cancer 2010;34(3):201-10.
2010: William Blackstock; Suzanne M Russo; W Warren Suh; Bard C Cosman; JOSEPH HERMAN; Mohammed Mohiuddin; Matthew M Poggi; William F Regine; Leonard B Saltz; William Small; Jennifer Zook; Andre Konski
ACR Appropriateness Criteria: local excision in early-stage rectal cancer.
Current problems in cancer 2010;34(3):193-200.
2010: Andrea Cercek Hanjis; Leonard B Saltz
Evolving treatment of advanced colorectal cancer.
Current oncology reports 2010;12(3):153-9.
2010: James Cassidy; Leonard B Saltz; Bruce J Giantonio; Fairooz F Kabbinavar; Herbert I Hurwitz; Ulrich-Peter Rohr
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.
Journal of cancer research and clinical oncology 2010;136(5):737-43.
2010: Nadine Jackson McCleary; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al Benson; Richard M Goldberg; Jeffrey A Meyerhardt
Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.
Cancer 2010;116(4):957-66.
2010: Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Jordan D Berlin; J Michael Berry; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Eric Rohren; David P Ryan; Leonard B Saltz; David Shibata; John M Skibber; William Small; Constantinos T Sofocleous; James P Thomas; Alan P Venook; Christopher Willett
NCCN clinical practice guidelines in oncology. Anal carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(1):106-20.
2009: Shuji Ogino; Jeffrey A Meyerhardt; Natsumi Irahara; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al B Benson; Richard M Goldberg; Monica M Bertagnolli; Charlie S Fuchs
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7322-9.
2009: A Okines; O Del Puerto; David Cunningham; I Chau; E Van Cutsem; Leonard B Saltz; J Cassidy
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial.
British journal of cancer 2009;101(7):1033-8.
2009: Alon Scope; Jocelyn A Lieb; Stephen W Dusza; Deborah L Phelan; Patricia L Myskowski; Leonard B Saltz; Allan C Halpern
A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption.
Journal of the American Academy of Dermatology 2009;61(4):614-20.
2009: Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard B Saltz; David Shibata; John M Skibber; Constantinos T Sofocleous; James P Thomas; Alan P Venook; Christopher Willett
NCCN Clinical Practice Guidelines in Oncology: rectal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(8):838-81.
2009: Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard B Saltz; David Shibata; John M Skibber; Constantinos T Sofocleous; James P Thomas; Alan P Venook; Christopher Willett
NCCN Clinical Practice Guidelines in Oncology: colon cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(8):778-831.
2009: William P Tew; Delia Radovich; Eileen O'Reilly; Gary K Schwartz; Deborah Schrag; Leonard B Saltz; David P Kelsen; Stacey Kepler; David H Ilson
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer.
Investigational new drugs 2009;27(4):366-73.
2009: George A. Poultsides; Elliot L Servais; Leonard B Saltz; Sujata M Patil; Nancy Kemeny; Jose G Guillem; Martin R Weiser; Larissa K Temple; Douglas Wong; Philip B Paty
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3379-84.
2009: Orlo H Clark; Al B Benson; Jordan D Berlin; Michael A Choti; Gerard M Doherty; Paul F Engstrom; John F Gibbs; Martin J Heslin; Anne Kessinger; Matthew H Kulke; Larry Kvols; Riad Salem; Leonard B Saltz; Manisha H Shah; Stephen Shibata; Jonathan R Strosberg; James C Yao
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(7):712-47.
2009: Martin R Weiser; Leonard B Saltz
Apples and oranges: the low and mid versus the upper rectum.
Nature reviews. Clinical oncology 2009;6(7):385-6.
2009: Leonard B Saltz
Current role of bevacizumab in colorectal cancer.
Clinical advances in hematology & oncology : H&O 2009;7(6):375-6.
2009: Mark W Onaitis; Rebecca P Petersen; John C Haney; Leonard B Saltz; Bernard J Park; Raja M Flores; Nabil P Rizk; Manjit S Bains; Joseph Dycoco; Thomas A D'Amico; David H Harpole; Nancy Kemeny; Valerie W Rusch; Robert J Downey
Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases.
The Annals of thoracic surgery 2009;87(6):1684-8.
2009: Barbara Burtness; Milan Anadkat; Surendra Basti; Miranda Hughes; Mario Lacouture; Joan S McClure; Patricia L Myskowski; Jennifer Paul; Clifford S Perlis; Leonard B Saltz; Sharon Spencer
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7 Suppl 1():S5-21; quiz S22-4.
2009: Geoffrey Y Ku; Eileen O'Reilly; Leonard B Saltz; Deborah Schrag; ROBERT G MAKI; David P Kelsen; David H Ilson
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.
Cancer investigation 2009;27(4):402-6.
2009: Daniel J Sargent; Claus-Henning Köhne; Hanna Sanoff; Brian M Bot; Matthew T Seymour; Aimery de Gramont; Ranier Porschen; Leonard B Saltz; Philippe Rougier; Christophe Tournigand; Jean-Yves Douillard; Richard J Stephens; Axel Grothey; Richard M Goldberg
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):1948-55.
2009: Monica M Bertagnolli; Donna Niedzwiecki; Carolyn Corlies Compton; Hejin P Hahn; Margaret Hall; Beatrice Damas; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Robert S Warren; Mark Redston
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1814-21.
2009: Monica M Bertagnolli; Robert S Warren; Donna Niedzwiecki; Elke Mueller; Carolyn Corlies Compton; Mark Redston; Margaret Hall; Hejin P Hahn; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Massimo Loda
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2116-22.
2009: Leonard B Saltz
Looking ahead: what will change in colorectal cancer treatment?
Gastrointestinal cancer research : GCR 2009;3(2 Suppl):S16-8.
2009: Diane Lauren Reidy; Laura H Tang; Leonard B Saltz
Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors.
Nature clinical practice. Oncology 2009;6(3):143-52.
2009: Neil H Segal; Leonard B Saltz
Evolving treatment of advanced colon cancer.
Annual review of medicine 2009;60():207-19.
2008: Andrea Cercek Hanjis; Leonard B Saltz
First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents.
Clinical colorectal cancer 2008;7 Suppl 2():S47-51.
2008: Leonard B Saltz
Second- and third-line treatment options for unresectable metastatic colorectal cancer.
Gastrointestinal cancer research : GCR 2008;2(6):299-302.
2008: David S Ettinger; Mark Agulnik; Mihaela Cristea; Keith Eaton; Panagiotis M Fidias; Jon P Gockerman; Omar Hameed; Charles Handorf; Elizabeth I Harris; Charlotte D Jacobs; Milind Javle; Nikhil I Khushalani; Larry Kvols; Renato Lenzi; Nancy L Lewis; Asif Rashid; Leonard B Saltz; Lawrence N Shulman; Jonathan S Zager; Weining Zhen
Occult primary.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(10):1026-60.
2008: Leonard B Saltz
Progress in cancer care: the hope, the hype, and the gap between reality and perception.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5020-1.
2008: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James P Thomas; Charlie S Fuchs
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4109-15.
2008: Neil H Segal; Leonard B Saltz
Is adjuvant therapy for stage II colon cancer worthwhile, and for whom?
Nature clinical practice. Gastroenterology & hepatology 2008;5(8):422-3.
2008: Leonard B Saltz
Colorectal Cancer Treatment: What's Next? (or: Is There Life After EGFR and VEGF?).
Gastrointestinal cancer research : GCR 2008;2(4 Suppl):S20-2.
2008: Hak-Mien Quah; Joanne F Chou; Mithat Gonen; Jinru Shia; Deborah Schrag; Leonard B Saltz; Karyn A Goodman; Bruce D Minsky; Douglas Wong; Martin R Weiser
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
Cancer 2008;113(1):57-64.
2008: Jennifer A Chan; Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Paul Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Robert S Warren; Monica Bertagnolli; Charlie S Fuchs
Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2008;299(21):2515-23.
2008: Leonard B Saltz
Combination chemotherapy: the fallback position?
Gastrointestinal cancer research : GCR 2008;2(3):154-5.
2008: Leonard B Saltz
Biomarkers in colorectal cancer: added value or just added expense?
Expert review of molecular diagnostics 2008;8(3):231-3.
2008: Daniel G Haller; Jim Cassidy; Stephen J Clarke; David Cunningham; Eric Van Cutsem; Paulo M Hoff; Mace L Rothenberg; Leonard B Saltz; Hans-Joachim Schmoll; Carmen Allegra; Joseph R Bertino; Jean-Yves Douillard; Bengt G Gustavsson; Gerard Milano; Michael O'Connell; Youcef Rustum; Josep Tabernero; Frank Gilberg; Florin Sirzén; Chris Twelves
Potential regional differences for the tolerability profiles of fluoropyrimidines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(13):2118-23.
2008: Jinru Shia; Laura H Tang; Martin R Weiser; Baruch Brenner; N Volkan Adsay; Edward B Stelow; Leonard B Saltz; Jing Qin; Ron Landmann; Gregory D Leonard; Deepti Dhall; Larissa K Temple; Jose G Guillem; Philip B Paty; David P Kelsen; Douglas Wong; David S Klimstra
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
The American journal of surgical pathology 2008;32(5):719-31.
2008: Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):2013-9.
2008: Jim Cassidy; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Leonard B Saltz
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):2006-12.
2008: W Warren Suh; A. William Blackstock; JOSEPH HERMAN; Andre Konski; Mohammed Mohiuddin; Matthew M Poggi; William F Regine; Bard C Cosman; Leonard B Saltz; Peter A S Johnstone
ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer.
International journal of radiation oncology, biology, physics 2008;70(5):1427-30.
2008: Gunnar Folprecht; Matthew T Seymour; Leonard B Saltz; Jean-Yves Douillard; Hartmut Hecker; Richard J Stephens; Timothy S Maughan; Eric Van Cutsem; Philippe Rougier; Emmanuel Mitry; Ute Schubert; Claus-Henning Köhne
Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1443-51.
2008: Ghassan K Abou-Alfa; Fidel-David Huitzil-Melendez; Eileen O'Reilly; Leonard B Saltz
Current management of advanced hepatocellular carcinoma.
Gastrointestinal cancer research : GCR 2008;2(2):64-70.
2008: Saul N Weingart; Elizabeth Brown; Peter B Bach; Kirby Eng; Shirley A Johnson; Timothy M Kuzel; Terry S Langbaum; R Donald Leedy; Raymond J Muller; Lee N Newcomer; Susan O'Brien; Denise Reinke; Mark Rubino; Leonard B Saltz; Ronald S Walters
NCCN Task Force Report: Oral chemotherapy.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6 Suppl 3():S1-14.
2008: Timothy R Asmis; Leonard B Saltz
Systemic therapy for colon cancer.
Gastroenterology clinics of North America 2008;37(1):287-95, ix.
2008: Kyle Holen; Leonard B Saltz; Ellen Hollywood; Konrad Burk; Axel R Hanauske
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor.
Investigational new drugs 2008;26(1):45-51.
2008: Martin R Weiser; Ron G Landmann; Michael W Kattan; Mithat Gonen; Jinru Shia; Joanne Chou; Philip B Paty; Jose G Guillem; Larissa K Temple; Deborah Schrag; Leonard B Saltz; Douglas Wong
Individualized prediction of colon cancer recurrence using a nomogram.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):380-5.
2008: A Duffy; Jeremy Kortmansky; Gary K Schwartz; Marinela Capanu; S Puleio; B Minsky; Leonard B Saltz; David P Kelsen; Eileen O'Reilly
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):86-91.
2007: Alon Scope; Anna Liza C Agero; Stephen W Dusza; Patricia L Myskowski; Jocelyn A Lieb; Leonard B Saltz; Nancy Kemeny; Allan C Halpern
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5390-6.
2007: Leonard B Saltz; Lee S Rosen; John L Marshall; Robert J Belt; Herbert I Hurwitz; S Gail Eckhardt; Emily Bergsland; Daniel G Haller; A Craig Lockhart; Caio Rocha Lima; Xin Huang; Samuel E DePrimo; Edna Chow-Maneval; Richard C Chao; Heinz J Lenz
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4793-9.
2007: Leonard B Saltz; Heinz-Josef Lenz; Hedy L Kindler; Howard Hochster; Scott Wadler; Paulo M Hoff; Nancy Kemeny; Ellen M Hollywood; Mithat Gonen; Marcus Quinones; Meroe Morse; Helen X Chen
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4557-61.
2007: Diane Lauren Reidy; Leonard B Saltz
Targeted strategies in the treatment of metastatic colon cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(9):983-90.
2007: Paul F Engstrom; J Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Dayna S Early; Marwan G Fakih; Charlie S Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Leonard B Saltz; David Shibata; John M Skibber; Alan P Venook
Rectal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(9):940-81.
2007: Paul F Engstrom; J Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Dayna S Early; Marwan G Fakih; Charlie S Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Leonard B Saltz; David Shibata; John M Skibber; Alan P Venook
Colon cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(9):884-925.
2007: Carmen Allegra; Charles D Blanke; Marc Buyse; Richard M Goldberg; Axel Grothey; Neal J Meropol; Leonard B Saltz; Alan P Venook; Greg Yothers; Daniel Sargent
End points in advanced colon cancer clinical trials: a review and proposal.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3572-5.
2007: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Frank B Hu; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James P Thomas; Charlie S Fuchs
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2007;298(7):754-64.
2007: Leonard B Saltz; Donna Niedzwiecki; Donna Hollis; Richard M Goldberg; Alexander Hantel; James P Thomas; Anthony L A Fields; Robert J Mayer
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3456-61.
2007: Diane Lauren Reidy; Ki Young Chung; John P Timoney; Vivian J Park; Ellen M Hollywood; Nancy T Sklarin; Raymond J Muller; Leonard B Saltz
Bevacizumab 5 mg/kg can be infused safely over 10 minutes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2691-5.
2007: Matthew M Poggi; W Warren Suh; Leonard B Saltz; Andre Konski; Mohammed Mohiuddin; JOSEPH HERMAN; Peter A Johnstone
ACR Appropriateness Criteria on treatment of anal cancer.
Journal of the American College of Radiology : JACR 2007;4(7):448-56.
2007: Ki Young Chung; Leonard B Saltz
Adjuvant therapy of colon cancer: current status and future directions.
Cancer journal (Sudbury, Mass.) 2007;13(3):192-7.
2007: Leonard B Saltz
Size matters. What can we learn from a small randomized trial?
Onkologie 2007;30(4):167.
2007: Michael D'Angelica; Peter Kornprat; Mithat Gonen; Ki Young Chung; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Nancy Kemeny; Leslie H Blumgart; Leonard B Saltz
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
Annals of surgical oncology 2007;14(2):759-65.
2006: Leonard B Saltz; Chris Easley; Peter Kirkpatrick
Panitumumab.
Nature reviews. Drug discovery 2006;5(12):987-8.
2006: Leonard B Saltz
Planned treatment interruptions and chemotherapy-free intervals in the treatment of metastatic colorectal cancer: time to start stopping?
Seminars in oncology 2006;33(6 Suppl 11):S28-32.
2006: Ghassan K Abou-Alfa; Lawrence H Schwartz; Sergio Ricci; Dino Amadori; Armando Santoro; Arie Figer; Jacques De Greve; Jean-Yves Douillard; Chetan Lathia; Brian Schwartz; Ian Taylor; Marius Moscovici; Leonard B Saltz
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4293-300.
2006: Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charlie S Fuchs
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3535-41.
2006: Rohit Bhargava; Beiyun Chen; David S Klimstra; Leonard B Saltz; Cyrus V Hedvat; Laura H Tang; William Gerald; Julie T Feldstein; Philip B Paty; Jing Qin; Jinru Shia
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
Cancer 2006;106(8):1857-62.
2006: Leonard B Saltz
Managing chemotherapy-induced diarrhea.
Clinical advances in hematology & oncology : H&O 2006;4(3):203-4.
2006: Ramesh Rengan; Philip B Paty; Douglas Wong; Jose G Guillem; Martin R Weiser; Larissa K Temple; Leonard B Saltz; Bruce D Minsky
Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders.
Clinical colorectal cancer 2006;5(6):413-21.
2006: Orlo H Clark; Jaffer A Ajani; Al B Benson; David Byrd; Gerard M Doherty; Paul F Engstrom; David S Ettinger; John F Gibbs; Martin J Heslin; Fouad Kandeel; Anne Kessinger; Matthew H Kulke; Larry K Kvols; Albert A Nemcek; John Olson; Thomas W Ratliff; Leonard B Saltz; David E Schteingart; Manisha H Shah; Stephen Shibata
Neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(2):102-38.
2005: Anton J Bilchik; Graeme Poston; Steven A Curley; Steven Strasberg; Leonard B Saltz; Rene Adam; Bernard Nordlinger; Philippe Rougier; Lee S Rosen
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9073-8.
2005: Leonard B Saltz
Epidermal growth factor receptor-negative colorectal cancer: is there truly such an entity?
Clinical colorectal cancer 2005;5 Suppl 2():S98-100.
2005: Arti Hurria; Supriya Gupta; Marjorie Zauderer; Enid Zuckerman; Harvey J Cohen; Hyman Muss; Miriam Rodin; Katherine S Panageas; Jimmie C Holland; Leonard B Saltz; Mark G Kris; Ariela Noy; Jorge Gomez; Ann Jakubowski; Clifford Hudis; Alice B Kornblith
Developing a cancer-specific geriatric assessment: a feasibility study.
Cancer 2005;104(9):1998-2005.
2005: Ki Young Chung; Leonard B Saltz
Antibody-based therapies for colorectal cancer.
The oncologist 2005;10(9):701-9.
2005: Jinru Shia; David S Klimstra; Allan R Li; Jing Qin; Leonard B Saltz; Julie T Feldstein; MUZAFFAR M AKRAM; Ki Young Chung; Davis Yao; Philip B Paty; William Gerald; Beiyun Chen
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1350-6.
2005: Deborah Schrag; Ki Young Chung; Carlos D Flombaum; Leonard B Saltz
Cetuximab therapy and symptomatic hypomagnesemia.
Journal of the National Cancer Institute 2005;97(16):1221-4.
2005: Leonard B Saltz
Metastatic colorectal cancer: is there one standard approach?
Oncology (Williston Park, N.Y.) 2005;19(9):1147-54; discussion 1154, 1157-8, 1160.
2005: Román Peréz-Soler; Leonard B Saltz
Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5235-46.
2005: Ramesh Rengan; Philip B Paty; Douglas Wong; Jose G Guillem; Martin R Weiser; Larissa K Temple; Leonard B Saltz; Bruce D Minsky
Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4905-12.
2005: Matthew Katz; Bruce D Minsky; Leonard B Saltz; Elyn Riedel; David B Chessin; Jose G Guillem
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.
International journal of radiation oncology, biology, physics 2005;62(5):1363-70.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Anal canal cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):510-5.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Rectal cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):492-508.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Colon cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):468-91.
2005: David B Chessin; Warren E Enker; Alfred M Cohen; Philip B Paty; Martin R Weiser; Leonard B Saltz; Bruce D Minsky; Douglas Wong; Jose G Guillem
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service.
Journal of the American College of Surgeons 2005;200(6):876-82; discussion 882-4.
2005: Jose G Guillem; David B Chessin; Jinru Shia; Harvey G Moore; Madhu Mazumdar; Bianca Bernard; Philip B Paty; Leonard B Saltz; Bruce D Minsky; Martin R Weiser; Larissa K Temple; Alfred M Cohen; Douglas Wong
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3475-9.
2005: Manish A Shah; Jeremy Kortmansky; Monica Motwani; Marija Drobnjak; Mithat Gonen; Sandy Yi; Amanda Weyerbacher; Carlos Cordon-Cardo; Robert Lefkowitz; Baruch Brenner; Eileen O'Reilly; Leonard B Saltz; William Tong; David P Kelsen; Gary K Schwartz
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3836-45.
2005: Manickam Muruganandham; Alan Alfieri; Cornelia Matei; Yuchun Chen; George Sukenick; Isabel Schemainda; Max Hasmann; Leonard B Saltz; Jason A Koutcher
Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3503-13.
2005: Roman Perez-Soler; Jean-Pierre Delord; Allan C Halpern; Karen Kelly; James Krueger; Bartomeu Massutí Sureda; Joachim von Pawel; Jennifer S Temel; Salvatore Siena; Denis Soulières; Leonard B Saltz; James Leyden
HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.
The oncologist 2005;10(5):345-56.
2005: Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren E Enker; Philip B Paty; Martin R Weiser; David S Klimstra; Leonard B Saltz; Bruce D Minsky; Douglas Wong
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.
Annals of surgery 2005;241(5):829-36; discussion 836-8.
2005: Hyman Muss; Jamie H Von Roenn; Lloyd Earl Damon; Lisa De Angelis; Lawrence E Flaherty; Paul M Harari; Karen Kelly; Michael P Kosty; Matthew J Loscalzo; Robert Mennel; Beverly S Mitchell; Joanne E Mortimer; Franco Muggia; Edith A Perez; Peter W T Pisters; Leonard B Saltz; Lidia Schapira; Joseph A Sparano
ACCO: ASCO core curriculum outline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):2049-77.
2005: Jeremy Kortmansky; Manish A Shah; Andreas Kaubisch; Amanda Weyerbacher; Sandy Yi; William Tong; Rebecca Sowers; Mithat Gonen; Eileen O'Reilly; Nancy Kemeny; David H Ilson; Leonard B Saltz; ROBERT G MAKI; David P Kelsen; Gary K Schwartz
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1875-84.
2005: Ki Young Chung; Jinru Shia; Nancy Kemeny; Manish A Shah; Gary K Schwartz; Archie N Tse; Audrey Hamilton; Dorothy Pan; Deborah Schrag; Lawrence H Schwartz; David S Klimstra; Daniel Fridman; David P Kelsen; Leonard B Saltz
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1803-10.
2005: David S Ettinger; Juan P Arnoletti; Jon P Gockerman; Charles Handorf; Kathleen Anne Havlin; Charlotte D Jacobs; Milind Javle; Larry Kvols; Renato Lenzi; Asif Rashid; Chris A Rhoades; John A Ridge; Leonard B Saltz; Lawrence N Shulman; Vernon K Sondak; John A Thompson; Przemyslaw Twardowski; Weining Zhen
Occult primary cancer clinical practice guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(2):214-33.
2005: Leonard B Saltz
Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
Nature clinical practice. Oncology 2005;2(1):20-1.
2004: Harvey G Moore; Jinru Shia; David S Klimstra; Leyo Ruo; Madhu Mazumdar; Gary K Schwartz; Bruce D Minsky; Leonard B Saltz; Jose G Guillem
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
Annals of surgical oncology 2004;11(11):955-61.
2004: Larissa K Temple; Lillian Hsieh; Douglas Wong; Leonard B Saltz; Deborah Schrag
Use of surgery among elderly patients with stage IV colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(17):3475-84.
2004: Jose G Guillem; Harvey G Moore; Timothy Akhurst; David S Klimstra; Leyo Ruo; Madhu Mazumdar; Bruce D Minsky; Leonard B Saltz; Douglas Wong; Steven M Larson
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.
Journal of the American College of Surgeons 2004;199(1):1-7.
2004: Robert P Akbari; Philip B Paty; Jose G Guillem; Martin R Weiser; Larissa K Temple; Bruce D Minsky; Leonard B Saltz; Douglas Wong
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.
Diseases of the colon and rectum 2004;47(7):1136-44.
2004: Leonard B Saltz; Neal J Meropol; Patrick J Loehrer; Michael Neil Needle; Justin Kopit; Robert J Mayer
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1201-8.
2004: Leonard B Saltz
Palliative management of rectal cancer: the roles of chemotherapy and radiation therapy.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2004;8(3):274-6.
2004: Gary K Schwartz; Joseph Bertino; Nancy Kemeny; Leonard B Saltz; David P Kelsen; William Tong; Mary Welch; Sandra Endres; Isaiah Dimery
Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer.
Anti-cancer drugs 2004;15(3):219-27.
2004: Harvey G Moore; Alicia E Gittleman; Bruce D Minsky; Douglas Wong; Philip B Paty; Martin R Weiser; Larissa K Temple; Leonard B Saltz; Jinru Shia; Jose G Guillem
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection.
Diseases of the colon and rectum 2004;47(3):279-86.
2004: P E Bernick; David S Klimstra; Jinru Shia; Bruce D Minsky; Leonard B Saltz; W Shi; Howard T Thaler; Jose G Guillem; Philip B Paty; Alfred M Cohen; Douglas Wong
Neuroendocrine carcinomas of the colon and rectum.
Diseases of the colon and rectum 2004;47(2):163-9.
2004: Melanie Royce; Eric K Rowinsky; Paulo M Hoff; John Coyle; Robert DeJager; Richard Pazdur; Leonard B Saltz
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum.
Investigational new drugs 2004;22(1):53-61.
2003: Leonard B Saltz
Another study of how to give fluorouracil?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3711-2.
2003: Joseph F Pizzolato; Leonard B Saltz
Irinotecan (Campto) in the treatment of pancreatic cancer.
Expert review of anticancer therapy 2003;3(5):587-93.
2003: Kathryn Beal; Douglas Wong; Jose G Guillem; Philip B Paty; Leonard B Saltz; Raquel Wagman; Bruce D Minsky
Primary adenocarcinoma of the anus treated with combined modality therapy.
Diseases of the colon and rectum 2003;46(10):1320-4.
2003: Paulo Marcelo Hoff; Leonard B Saltz; Charles D von Blanke; Eric van Custem
[Oxaliplatin: high activity at all stages of colon carcinomas].
Onkologie 2003;26(Suppl 3):2-10.
2003: Joseph F Pizzolato; Leonard B Saltz
The camptothecins.
Lancet 2003;361(9376):2235-42.
2003: Leonard B Saltz
Understanding and managing chemotherapy-induced diarrhea.
The journal of supportive oncology 2003;1(1):35-46; discussion 38-41, 45-6.
2003: Paul F Engstrom; Al B Benson; Leonard B Saltz
Anal canal cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1(1):64-8.
2003: Paul F Engstrom; Al B Benson; Leonard B Saltz
Rectal cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1(1):54-63.
2003: Paul F Engstrom; Al B Benson; Leonard B Saltz
Colon cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1(1):40-53.
2003: Harvey G Moore; Elyn Riedel; Bruce D Minsky; Leonard B Saltz; Philip B Paty; Douglas Wong; Alfred M Cohen; Jose G Guillem
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy.
Annals of surgical oncology 2003;10(1):80-5.
2002: Kyle D Holen; David S Klimstra; Amanda J Hummer; Mithat Gonen; Kevin Conlon; Murray F Brennan; Leonard B Saltz
Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(24):4673-8.
2002: Garrett M Nash; Leonard B Saltz; Nancy Kemeny; Bruce D Minsky; Sunil Sharma; Gary K Schwartz; David H Ilson; Eileen O'Reilly; David P Kelsen; Daniel R Nathanson; Martin R Weiser; Jose G Guillem; Douglas Wong; Alfred M Cohen; Philip B Paty
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease.
Annals of surgical oncology 2002;9(10):954-60.
2002: Leonard B Saltz; Bruce D Minsky
Adjuvant therapy of cancers of the colon and rectum.
The Surgical clinics of North America 2002;82(5):1035-58.
2002: Deborah Schrag; Sheryl L Rifas-Shiman; Leonard B Saltz; Peter B Bach; Colin B Begg
Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):3999-4005.
2002: Nancy Kemeny; William Tong; Mithat Gonen; Jennifer Stockman; C Di Lauro; Jerrold B Teitcher; P White; C Price; Leonard B Saltz; Sunil Sharma; M A Graham
Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1490-6.
2002: Sunil Sharma; Nancy Kemeny; David P Kelsen; David H Ilson; Eileen O'Reilly; Sara Zaknoen; C Baum; Paul Statkevich; Ellen M Hollywood; Y Zhu; Leonard B Saltz
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1067-71.
2002: Leyo Ruo; SK Tickoo; David S Klimstra; Bruce D Minsky; Leonard B Saltz; Madhu Mazumdar; Philip B Paty; Douglas Wong; Steven M Larson; Alfred M Cohen; Jose G Guillem
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy.
Annals of surgery 2002;236(1):75-81.
2002: Gary K Schwartz; Eileen O'Reilly; David H Ilson; Leonard B Saltz; Sunil Sharma; William Tong; Peter Maslak; Maxine Stoltz; Larry Eden; Pam Perkins; Sandra Endres; John Barazzoul; David Spriggs; David P Kelsen
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2157-70.
2002: John P Timoney; Mark G Malkin; D M Leone; Jeffrey S Groeger; Mark L Heaney; DL Keefe; M Klang; Charles D Lucarelli; Raymond J Muller; S L Eng; M Connor; Trudy N Small; Arthur E Brown; Leonard B Saltz
Safe and cost effective use of alteplase for the clearance of occluded central venous access devices.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1918-22.
2002: Spiros P Hiotis; Sharon M Weber; Alfred M Cohen; Bruce D Minsky; Philip B Paty; Jose G Guillem; Raquel Wagman; Leonard B Saltz; Douglas Wong
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients.
Journal of the American College of Surgeons 2002;194(2):131-5; discussion 135-6.
2001: Alfred T Culliford; Ari D Brooks; Sunil Sharma; Leonard B Saltz; Gary K Schwartz; Eileen O'Reilly; David H Ilson; Nancy Kemeny; David P Kelsen; Jose G Guillem; Douglas Wong; Alfred M Cohen; Philip B Paty
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.
Annals of surgical oncology 2001;8(10):787-95.
2001: Sunil Sharma; Nancy Kemeny; Gary K Schwartz; David P Kelsen; Eileen O'Reilly; David H Ilson; John Coyle; Robert L De Jager; M P Ducharme; S Kleban; Ellen M Hollywood; Leonard B Saltz
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3963-70.
2001: Renier J Brentjens; Leonard B Saltz
Islet cell tumors of the pancreas: the medical oncologist's perspective.
The Surgical clinics of North America 2001;81(3):527-42.
2001: Nancy Kemeny; Mithat Gonen; Deidre Sullivan; Lawrence H Schwartz; FM Benedetti; Leonard B Saltz; Jennifer Stockman; Yuman Fong; William R Jarnagin; Joseph Bertino; William Tong; Philip B Paty
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2687-95.
2001: K D Holen; Leonard B Saltz
New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
The lancet oncology 2001;2(5):290-7.
2001: PM Sanz-Altamira; Eileen O'Reilly; KE Stuart; L Raeburn; CM Steger; Nancy Kemeny; Leonard B Saltz
A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):501-4.
2001: Gary K Schwartz; David H Ilson; Leonard B Saltz; Eileen O'Reilly; William Tong; Peter Maslak; J Werner; P Perkins; M Stoltz; David P Kelsen
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1985-92.
2001: A Grann; C Feng; Douglas Wong; Leonard B Saltz; Philip P Paty; Jose G Guillem; Alfred M Cohen; Bruce D Minsky
Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma.
International journal of radiation oncology, biology, physics 2001;49(4):987-95.
2001: Aviram Nissan; Jose G Guillem; Philip B Paty; W Douglas Wong; Bruce D Minsky; Leonard B Saltz; Alfred M Cohen
Abdominoperineal resection for rectal cancer at a specialty center.
Diseases of the colon and rectum 2001;44(1):27-35; discussion 35-6.
2001: Leonard B Saltz
Perspectives on fluorinated pyrimidine use in gastrointestinal and breast oncology.
Oncology (Williston Park, N.Y.) 2001;15(1 Suppl 2):73-8.
2001: Leonard B Saltz
Oral chemotherapy for colorectal cancer: some economic considerations.
Oncology (Williston Park, N.Y.) 2001;15(1 Suppl 2):29-32.
2001: Leonard B Saltz; Jean-Yves Douillard; Nicoletta Pirotta; M Alakl; Gabriela Gruia; L Awad; Gary L Elfring; Paula K Locker; Langdon L Miller
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.
The oncologist 2001;6(1):81-91.
2001: Leonard B Saltz
Irinotecan: a new agent comes of age.
The oncologist 2001;6(1):65.
2001: Eileen O'Reilly; KE Stuart; PM Sanz-Altamira; Gary K Schwartz; CM Steger; L Raeburn; Nancy Kemeny; David P Kelsen; Leonard B Saltz
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.
Cancer 2001;91(1):101-5.
2000: Leonard B Saltz
Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer.
Oncology (Williston Park, N.Y.) 2000;14(12 Suppl 14):47-50.
2000: D I Rosenthal; Daniel G Haller; Leonard B Saltz; D Semple; Bruce D Minsky
Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin.
Oncology (Williston Park, N.Y.) 2000;14(10 Suppl 9):59-62.
2000: Leonard B Saltz; J V Cox; Charles D Blanke; L S Rosen; L Fehrenbacher; M J Moore; J A Maroun; S P Ackland; Paula K Locker; Nicoletta Pirotta; Gary L Elfring; Langdon L Miller
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.
The New England journal of medicine 2000;343(13):905-14.
2000: Kaled M. Alektiar; Michael J Zelefsky; Philip B Paty; Jose G Guillem; Leonard B Saltz; Alfred M Cohen; Bruce D Minsky
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.
International journal of radiation oncology, biology, physics 2000;48(1):219-26.
2000: Madhu J John; GS Merrick; Lawrence R Coia; Bruce D Minsky; JL Bader; NA Janjan; D Raben; tyvin rich; Seth A Rosenthal; Joel E Tepper; D Ota; Leonard B Saltz; Steven Leibel
Anal cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1501-11.
2000: Leonard B Saltz; D Raben; Bruce D Minsky; JL Bader; Lawrence R Coia; NA Janjan; Madhu J John; GS Merrick; tyvin rich; Seth A Rosenthal; Joel E Tepper; D Ota; Steven Leibel
Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1491-9.
2000: Joel E Tepper; JL Bader; NA Janjan; Bruce D Minsky; Lawrence R Coia; Madhu J John; GS Merrick; D Raben; tyvin rich; Seth A Rosenthal; D Ota; Leonard B Saltz; Steven Leibel
Locally unresectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1481-90.
2000: tyvin rich; D Ota; Seth A Rosenthal; Bruce D Minsky; JL Bader; Lawrence R Coia; NA Janjan; Madhu J John; GS Merrick; D Raben; Joel E Tepper; Leonard B Saltz; Steven Leibel
Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1473-80.
2000: Cindy A Eads; Kathleen D Danenberg; K Kawakami; Leonard B Saltz; C Blake; Darryl Shibata; Peter V Danenberg; Peter W Laird
MethyLight: a high-throughput assay to measure DNA methylation.
Nucleic acids research 2000;28(8):E32.
2000: RS Chamberlain; D Canes; Karen T Brown; Leonard B Saltz; William R Jarnagin; Yuman Fong; Leslie H Blumgart
Hepatic neuroendocrine metastases: does intervention alter outcomes?
Journal of the American College of Surgeons 2000;190(4):432-45.
2000: Jose G Guillem; J Puig-La Calle; Timothy Akhurst; SK Tickoo; Leyo Ruo; Bruce D Minsky; Marc J Gollub; David S Klimstra; Madhu Mazumdar; Philip B Paty; Homer A Macapinlac; Henry Yeung; Leonard B Saltz; Ronald D Finn; Yusuf E Erdi; John L Humm; Alfred M Cohen; Steven M Larson
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography.
Diseases of the colon and rectum 2000;43(1):18-24.
2000: S Sharma; Leonard B Saltz
Oral chemotherapeutic agents for colorectal cancer.
The oncologist 2000;5(2):99-107.
2000: Jonathan Koea; Jose G Guillem; Kevin C Conlon; Bruce D Minsky; Leonard B Saltz; A Cohen
Role of laparoscopy in the initial multimodality management of patients with near-obstructing rectal cancer.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2000;4(1):105-8.
1999: David H Ilson; Leonard B Saltz; Peter C Enzinger; Y Huang; Alice B Kornblith; Marc J Gollub; Eileen O'Reilly; Gary K Schwartz; J DeGroff; G Gonzalez; David P Kelsen
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3270-5.
1999: P N Cheng; Leonard B Saltz
Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
Cancer 1999;86(6):944-8.
1999: Raquel Wagman; Bruce D Minsky; Alfred M Cohen; Leonard B Saltz; Philip B Paty; Jose G Guillem
Conservative management of rectal cancer with local excision and postoperative adjuvant therapy.
International journal of radiation oncology, biology, physics 1999;44(4):841-6.
1999: Cindy A Eads; Kathleen D Danenberg; K Kawakami; Leonard B Saltz; Peter V Danenberg; Peter W Laird
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression.
Cancer research 1999;59(10):2302-6.
1999: Peter C Enzinger; David H Ilson; Leonard B Saltz; L K Martin; David P Kelsen
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
Cancer 1999;85(6):1213-7.
1999: J Rubin; J Ajani; W Schirmer; A P Venook; R Bukowski; Rodney F Pommier; Leonard B Saltz; P Dandona; L Anthony
Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):600-6.
1999: Leonard B Saltz
The role of irinotecan in colorectal cancer.
Current oncology reports 1999;1(2):155-60.
1999: Eileen O'Reilly; David H Ilson; Leonard B Saltz; Robert T Heelan; L Martin; David P Kelsen
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma.
Cancer investigation 1999;17(3):195-200.
1998: Leonard B Saltz; David Spriggs; Larry J Schaaf; Gary K Schwartz; David H Ilson; Nancy Kemeny; J Kanowitz; CM Steger; M Eng; P Albanese; D Semple; CK Hanover; Gary L Elfring; Langdon L Miller; David P Kelsen
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3858-65.
1998: Peter C Enzinger; David H Ilson; Leonard B Saltz; Eileen O'Reilly; David P Kelsen
Irinotecan and cisplatin in upper gastrointestinal malignancies.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):110-3.
1998: Leonard B Saltz
Irinotecan in the first-line treatment of colorectal cancer.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):54-8.
1997: Leonard B Saltz; Gary K Schwartz; David H Ilson; V Quan; David P Kelsen
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer.
American journal of clinical oncology 1997;20(6):621-5.
1997: Leonard B Saltz; Nancy Kemeny; W Tong; J Harrison; R Berkery; David P Kelsen
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma.
Cancer 1997;80(9):1727-32.
1997: Nancy Kemeny; Leonard B Saltz; A Cohen
Adjuvant therapy of colorectal cancer.
Surgical oncology clinics of North America 1997;6(4):699-722.
1997: A M Cohen; David P Kelsen; Leonard B Saltz; B D Minsky; H Nelson; Ridzuan Farouk; Leonard L Gunderson; Fabrizio Michelassi; Richard B Arenas; R L Schilsky; C G Willet
Adjuvant therapy for colorectal cancer.
Current problems in surgery 1997;34(8):601-76.
1997: A Grann; Bruce D Minsky; Alfred M Cohen; Leonard B Saltz; Jose G Guillem; Philip B Paty; David P Kelsen; Nancy Kemeny; David H Ilson; J Bass-Loeb
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
Diseases of the colon and rectum 1997;40(5):515-22.
1997: Gary K Schwartz; D Ward; Leonard B Saltz; Ephraim S Casper; T Spiess; E Mullen; J Woodworth; R Venuti; P Zervos; A M Storniolo; David P Kelsen
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(4):537-43.
1997: David P Kelsen; D Martin; J O'Neil; Gary K Schwartz; Leonard B Saltz; M T Sung; R von Borstel; Joseph Bertino
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1511-7.
1997: Leonard B Saltz; John Janik
Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?
Seminars in oncology 1997;24(1 Suppl 5):S5-26-S5-30.
1997: Bruce D Minsky; Alfred M Cohen; Warren E Enker; Leonard B Saltz; Jose G Guillem; Philip B Paty; David P Kelsen; Nancy Kemeny; David H Ilson; J Bass; J Conti
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
International journal of radiation oncology, biology, physics 1997;37(2):289-95.
1997: Leonard B Saltz; David P Kelsen
Adjuvant treatment of colorectal cancer.
Annual review of medicine 1997;48():191-202.
1996: Leonard B Saltz; J Kanowitz; Nancy Kemeny; Larry J Schaaf; David Spriggs; B A Staton; R Berkery; C Steger; M Eng; A Dietz; P Locker; David P Kelsen
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2959-67.
1996: Gary K Schwartz; K Christman; Leonard B Saltz; E Casper; V Quan; J Bertino; Daniel S Martin; J Colofiore; David P Kelsen
A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
Cancer 1996;78(9):1988-95.
1996: A Tiersten; Leonard B Saltz
Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):2043-6.
1996: David P Kelsen; Martin S Karpeh; Gary K Schwartz; Hans Gerdes; C Lightdale; J Botet; G Lauers; David S Klimstra; Y Huang; Leonard B Saltz; V Quan; Murray F Brennan
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1818-28.
1996: J A Conti; Nancy Kemeny; Leonard B Saltz; Y Huang; William P Tong; T C Chou; M Sun; S Pulliam; C Gonzalez
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):709-15.
1996: Leonard B Saltz; Y Shimada; D Khayat
CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A Suppl 3():S24-31.
1995: David H Ilson; M Sirott; Leonard B Saltz; Robert T Heelan; Y Huang; R Keresztes; David P Kelsen
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Cancer 1995;75(9):2197-202.
1995: Leonard B Saltz; Cynthia G Leichman; C W Young; F M Muggia; J A Conti; T Spiess; Susan Jeffers; L P Leichman
A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer.
Cancer 1995;75(3):782-5.
1995: J A Conti; Nancy Kemeny; Leonard B Saltz; A M André; D D Grossano; Joseph R Bertino
Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
Cancer 1995;75(3):769-74.
1994: Leonard B Saltz; B Murphy; Nancy Kemeny; J Bertino; William Tong; Deborah Keefe; Y Tzy-Jun; Y Tao; David P Kelsen; J P O'Brien
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance.
Cancer 1994;74(10):2757-64.
1994: David P Kelsen; Leonard B Saltz; Alfred M Cohen; Tzy-Jyun Yao; Warren E Enker; William Tong; Y Tao; Joseph R Bertino
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Cancer 1994;74(8):2224-33.
1994: Leonard B Saltz; Nancy Kemeny; Gary K Schwartz; David P Kelsen
A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.
Cancer 1994;74(3):958-61.
1994: Valerie W Rusch; Leonard B Saltz; Venkatraman E Seshan; Robert J Ginsberg; P McCormack; M Burt; Maurie Markman; David P Kelsen
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1156-63.
1994: Bruce D Minsky; A Cohen; Warren E Enker; David P Kelsen; Nancy Kemeny; David H Ilson; Jose G Guillem; Leonard B Saltz; J Frankel; J Conti
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer.
Cancer 1994;73(2):273-80.
1994: K Christman; David P Kelsen; Leonard B Saltz; P G Tarassoff
Phase II trial of gemcitabine in patients with advanced gastric cancer.
Cancer 1994;73(1):5-7.
1993: Leonard B Saltz; M Sirott; C Young; William Tong; D Niedzwiecki; Y Tzy-Jyun; Y Tao; B Trochanowski; P Wright; K Barbosa
Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor.
Journal of the National Cancer Institute 1993;85(18):1499-507.
1993: Leonard B Saltz; Gregory Y Lauwers; J Wiseberg; David P Kelsen
A phase II trial of carboplatin in patients with advanced APUD tumors.
Cancer 1993;72(2):619-22.
1993: Leonard B Saltz; B Trochanowski; M Buckley; B Heffernan; D Niedzwiecki; Y Tao; David P Kelsen
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.
Cancer 1993;72(1):244-8.
1993: Bruce D Minsky; Alfred M Cohen; Nancy Kemeny; Warren E Enker; David P Kelsen; Leonard B Saltz; J Frankel
The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
Cancer 1993;71(11):3486-92.
1993: K Christman; Leonard B Saltz; Gary K Schwartz; C Friedrich; David P Kelsen
Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression?
Journal of the National Cancer Institute 1993;85(10):826-7.
1993: Bruce D Minsky; Alfred M Cohen; Nancy Kemeny; Warren E Enker; David P Kelsen; Gary K Schwartz; Leonard B Saltz; J Dougherty; J Frankel; J Wiseberg
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
International journal of radiation oncology, biology, physics 1993;25(5):821-7.
1993: O T Atiq; David P Kelsen; M H Shiu; Leonard B Saltz; William Tong; D Niedzwiecki; B Trochanowski; S Lin; F Toomasi; Murray F Brennan
Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):425-33.
1992: Leonard B Saltz; David P Kelsen
Combined-modality therapy in the treatment of local-regional esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(10):793-9.
1992: Bruce D Minsky; Alfred M Cohen; Nancy Kemeny; Warren E Enker; David P Kelsen; B Reichman; Leonard B Saltz; Elin R Sigurdson; J Frankel
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1218-24.
1992: Valerie W Rusch; D Niedzwiecki; Y Tao; C Menendez-Botet; Ann M Dnistrian; David P Kelsen; Leonard B Saltz; Maurie Markman
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):1001-6.
1992: David P Kelsen; O T Atiq; Leonard B Saltz; D Niedzwiecki; D Ginn; D Chapman; Robert T Heelan; C Lightdale; V Vinciguerra; Murray F Brennan
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):541-8.
1992: David P Kelsen; D Lovett; J Wong; Leonard B Saltz; M Buckley; P Murray; Robert T Heelan; C Lightdale
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(2):269-74.
1992: Bruce D Minsky; Alfred M Cohen; Nancy Kemeny; Warren E Enker; David P Kelsen; B Reichman; Leonard B Saltz; Elin R Sigurdson; J Frankel
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):79-84.
1992: Bruce D Minsky; Alfred M Cohen; Warren E Enker; David P Kelsen; Nancy Kemeny; B Riechman; Leonard B Saltz; Elin R Sigurdson; J Frankel
Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.
International journal of radiation oncology, biology, physics 1992;22(1):139-45.
1991: Leonard B Saltz
Drug treatment of colorectal cancer. Current status.
Drugs 1991;42(4):616-27.
1991: Bruce D Minsky; Nancy Kemeny; Alfred M Cohen; Warren E Enker; David P Kelsen; B Reichman; Leonard B Saltz; Elin R Sigurdson; J Frankel
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.
Cancer 1991;67(11):2859-66.
1990: Leonard B Saltz; David P Kelsen
A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies.
Cancer 1990;66(8):1688-91.
1990: P I Yi; M Coleman; Leonard B Saltz; L Norton; A A Topilow; K Adler; B Bernhardt
Chemotherapy for large cell lymphoma: a status update.
Seminars in oncology 1990;17(1):60-73.
1990: N Scott McNutt; B R Smoller; M Kline; S R Cohen; A Hsu; Leonard B Saltz; K Cash; B Safai
Angiocentric T-cell lymphoma associated with human T-cell lymphotropic virus type I infection.
Archives of pathology & laboratory medicine 1990;114(2):170-5.
1990: Leonard B Saltz; D M Knowles; S Mechanic; P Pasley; R Brooks; M Wakai; Nicholas Chiorazzi
Augmentation by cytochalasin B of antigen receptor-mediated activation of normal and malignant human B lymphocytes.
Scandinavian journal of immunology 1990;31(1):109-19.